Interplay role of microalgae and bio-carriers in hybrid membrane bioreactors on wastewater treatment, membrane fouling, and microbial communities
Environmental Pollution · 2023
DOI: 10.1016/j.envpol.2023.122764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Pollution, 2023. Verfasst von Shahla Radmehr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Separation and Purification Technology, School of Engineering Science, Lappeenranta-Lahti University of Technology LUT, P.O. Box 20, La…. Hauptthemen laut MEDLINE: Microalgae, Microbiota, Water Purification. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.
Abstract (Originalsprache)
Algal membrane bioreactors (algae-MBRs) and advanced hybrid biocarrier algal membrane bioreactors (hybrid algae-MBRs) have been investigated to improve the performance of conventional MBRs (C-MBRs). Maximum chemical oxygen demand and nutrient removal efficiencies, similar to the maximum biomass growth rate, chlorophyll-a concentration, and balanced microbial growth, were achieved in the hybrid algae-MBR inoculated with polyethylene biocarriers and algal cells. During the 90 days of operation, the hybrid algae-MBR demonstrated lower membrane fouling without membrane washing, whereas the C-MBR and algae-MBR were washed seven and four times, respectively. Compared to the C-MBR, both the algal MBR and hybrid algal MBR exhibited higher levels of nitrification, with 6 and 10 % greater rates, respectively. In addition, they displayed significant improvements in ammonium biomass uptake compared to the C-MBR, with increases of 30 and 37 %, respectively. In the algae-MBR, the chlorophyll-a results showed proliferation of algae over time. However, biocarriers that provide an additional surface for microbial growth, particularly algal strains, inhibit algal proliferation and result in balanced microbial growth (based on chlorophyll-a/MLVSS) in the bulk solution of the hybrid algae-MBR. In addition, the oxygen mass balance estimated that photosynthesis provided 45 % of the dissolved oxygen required in the studied algal reactors, whereas mixing provided the remainder. Additionally, microbial sequencing results indicated that the microbial communities (e.g., Candidatus, Cloacibacterium, and Falavobacterium) were altered by introducing microalgae and biocarriers that affected the activity of different microorganisms, changed the sludge and fouling layer properties, and improved the performance of the C-MBRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Separation and Purification Technology, School of Engineering Science, Lappeenranta-Lahti University of Technology LUT, P.O. Box 20, Lappeenranta, FIN-53851, Finland, Finland. Electronic address: shahla.ra…
- Department of Separation and Purification Technology, School of Engineering Science, Lappeenranta-Lahti University of Technology LUT, P.O. Box 20, Lappeenranta, FIN-53851, Finland, Finland.
Förderung
- European Regional Development Fund
Zitieren
APA
Radmehr, S., Kallioinen-Mänttäri, M., & Mänttäri, M. (2023). Interplay role of microalgae and bio-carriers in hybrid membrane bioreactors on wastewater treatment, membrane fouling, and microbial communities. Environmental Pollution. https://doi.org/10.1016/j.envpol.2023.122764
Vancouver
Radmehr S, Kallioinen-Mänttäri M, Mänttäri M. Interplay role of microalgae and bio-carriers in hybrid membrane bioreactors on wastewater treatment, membrane fouling, and microbial communities. Environmental Pollution. 2023. doi:10.1016/j.envpol.2023.122764
BibTeX
@article{Radmehr2023,
author = {Radmehr, Shahla and Kallioinen-Mänttäri, Mari and Mänttäri, Mika},
title = {Interplay role of microalgae and bio-carriers in hybrid membrane bioreactors on wastewater treatment, membrane fouling, and microbial communities},
journal = {Environmental Pollution},
year = {2023},
doi = {10.1016/j.envpol.2023.122764}
}
EUVIMED